Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 3
1984 3
1985 3
1987 2
1989 1
1990 2
1991 5
1992 5
1993 1
1994 9
1995 2
1996 5
1997 7
1998 7
1999 4
2000 11
2001 3
2002 3
2004 2
2005 5
2006 4
2007 4
2008 2
2009 2
2010 4
2011 1
2013 1
2014 2
2015 1
2016 1
2017 2
2019 3
2020 1
2022 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

109 results
Results by year
Filters applied: . Clear all
Page 1
Systematic review: agranulocytosis induced by nonchemotherapy drugs.
Andersohn F, Konzen C, Garbe E. Andersohn F, et al. Ann Intern Med. 2007 May 1;146(9):657-65. doi: 10.7326/0003-4819-146-9-200705010-00009. Ann Intern Med. 2007. PMID: 17470834 Review.
STUDY SELECTION: Published case reports of patients with nonchemotherapy drug-induced agranulocytosis. DATA EXTRACTION: One reviewer abstracted details about cases and assessed causality between drug intake and agranulocytosis by using World Health Organization asse …
STUDY SELECTION: Published case reports of patients with nonchemotherapy drug-induced agranulocytosis. DATA EXTRACTION: One reviewer …
Drug-induced immune neutropenia/agranulocytosis.
Curtis BR. Curtis BR. Immunohematology. 2014;30(2):95-101. Immunohematology. 2014. PMID: 25247619 Review.
Reduction in neutrophils below an absolute count of 500 cells/pL is termed severe neutropenia or agranulocytosis. Drug-induced immune neutropenia (DIIN) occurs when drug-dependent antibodies form against neutrophil membrane glycoproteins and cause neutrophil destruction. . …
Reduction in neutrophils below an absolute count of 500 cells/pL is termed severe neutropenia or agranulocytosis. Drug-induced immune …
Non-chemotherapy drug-induced neutropenia: key points to manage the challenges.
Curtis BR. Curtis BR. Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):187-193. doi: 10.1182/asheducation-2017.1.187. Hematology Am Soc Hematol Educ Program. 2017. PMID: 29222255 Free PMC article. Review.
The drugs most frequently associated with IDIN include metamizole, clozapine, sulfasalazine, thiamazole, carbimazole, amoxicillin, cotrimoxazole, ticlopidine, and valganciclovir. The idiosyncratic nature of IDIN, the lack of mouse models and diagnostic testing, and its low …
The drugs most frequently associated with IDIN include metamizole, clozapine, sulfasalazine, thiamazole, carbimazole, amoxicillin, cotrimoxa …
Agranulocytosis and hepatic toxicity with ticlopidine therapy: a case report.
Previtera AM, Pagani R. Previtera AM, et al. J Med Case Rep. 2010 Aug 12;4:269. doi: 10.1186/1752-1947-4-269. J Med Case Rep. 2010. PMID: 20704700 Free PMC article.
More serious, but less frequent, adverse effects are hematological dyscrasia and cholestatic hepatitis. We report a rare case of agranulocytosis associated with hepatic toxicity, probably related to the use of ticlopidine. ...Upon admission, her blood tests were nor …
More serious, but less frequent, adverse effects are hematological dyscrasia and cholestatic hepatitis. We report a rare case of agranulo
The antiplatelet effects of ticlopidine and clopidogrel.
Sharis PJ, Cannon CP, Loscalzo J. Sharis PJ, et al. Ann Intern Med. 1998 Sep 1;129(5):394-405. doi: 10.7326/0003-4819-129-5-199809010-00009. Ann Intern Med. 1998. PMID: 9735068 Review.
Ticlopidine and clopidogrel achieve antiplatelet effects by inhibiting the binding of adenosine 5'-disphosphate to its platelet receptor. Ticlopidine was first shown to decrease major events compared with placebo or aspirin in patients with stroke or recent transien
Ticlopidine and clopidogrel achieve antiplatelet effects by inhibiting the binding of adenosine 5'-disphosphate to its platelet recep
Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states.
Saltiel E, Ward A. Saltiel E, et al. Drugs. 1987 Aug;34(2):222-62. doi: 10.2165/00003495-198734020-00003. Drugs. 1987. PMID: 3304967 Review.
In a large number of animal models, ticlopidine markedly inhibits thrombus formation or graft occlusion. ...Bleeding is infrequent except possibly in patients receiving ticlopidine prior to some surgical procedures....
In a large number of animal models, ticlopidine markedly inhibits thrombus formation or graft occlusion. ...Bleeding is infrequent ex …
Ticlopidine.
[No authors listed] [No authors listed] Lancet. 1991 Feb 23;337(8739):459-60. Lancet. 1991. PMID: 1671474 No abstract available.
[Idiosyncratic drug-induced agranulocytosis].
Federici L, Weitten T, Alt M, Blaison G, Zamfir A, Audhuy B, Maloisel F, Andrès E. Federici L, et al. Presse Med. 2008 Sep;37(9):1327-33. doi: 10.1016/j.lpm.2008.03.013. Epub 2008 Jul 17. Presse Med. 2008. PMID: 18644319 Review. French.
Idiosyncratic drug-induced agranulocytosis is a potential adverse event of most drugs, rare but life-threatening. ...The principal drugs associated with it are antithyroid drugs, antibiotics including trimethoprim, sulfamethoxazole, and beta-lactamines, ticlopidine, …
Idiosyncratic drug-induced agranulocytosis is a potential adverse event of most drugs, rare but life-threatening. ...The principal dr …
[Agranulocytosis and ticlopidine].
Fernández Esteban V, Cuevas Ruiz B, Cuevas Ruiz MV, Saralegui Reta I, Ochoa Gómez J. Fernández Esteban V, et al. An Med Interna. 2001 May;18(5):281-2. An Med Interna. 2001. PMID: 11496567 Spanish. No abstract available.
Non-chemotherapy drug-induced agranulocytosis.
Garbe E. Garbe E. Expert Opin Drug Saf. 2007 May;6(3):323-35. doi: 10.1517/14740338.6.3.323. Expert Opin Drug Saf. 2007. PMID: 17480181 Review.
Agranulocytosis is characterised by a peripheral neutrophil count < 0.5 x 10(9)/l. It often manifests with a severe sore throat, but isolated fever, pneumonia or septicaemia are not uncommon. Agranulocytosis may be caused by many drugs. High-risk drugs include an
Agranulocytosis is characterised by a peripheral neutrophil count < 0.5 x 10(9)/l. It often manifests with a severe sore throat, b
109 results